Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2006 1
2016 1
2019 2
2020 2
2024 1
2025 7
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

14 results

Results by year

Filters applied: . Clear all
Page 1
Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Disease and Injury and Risk Factor Collaborators. GBD 2023 Disease and Injury and Risk Factor Collaborators. Lancet. 2025 Oct 18;406(10513):1873-1922. doi: 10.1016/S0140-6736(25)01637-X. Epub 2025 Oct 12. Lancet. 2025. PMID: 41092926 Free PMC article.
Co-administration of probiotics and vitamin D reduced disease severity and complications in patients with Parkinson's disease: a randomized controlled clinical trial.
Zali A, Hajyani S, Salari M, Tajabadi-Ebrahimi M, Mortazavian AM, Pakpour B. Zali A, et al. Psychopharmacology (Berl). 2024 Sep;241(9):1905-1914. doi: 10.1007/s00213-024-06606-9. Epub 2024 May 28. Psychopharmacology (Berl). 2024. PMID: 38805039 Clinical Trial.
These patients were randomly allocated to one of the two treatment groups: Group A, who received probiotic/vitamin D supplements (n = 23), and Group B who received placebo capsules (n = 23) for 12 weeks. As primary outcomes, Interferon-Gamma (IFN-gamma), interleukin …
These patients were randomly allocated to one of the two treatment groups: Group A, who received probiotic/vitamin D supplements (n = …
Short-term efficacy of peripheral nerve stimulation for essential tremor in a randomized double-blind controlled trial.
Samiee R, Jameie M, Rahmati M, Looha MA, Mobader S, Tafakhori A, Sarraf P, Amirifard H, Burachaloo SR, Ghabaee M, Amanollahi M, Tajabadi Z, Harirchian MH. Samiee R, et al. Sci Rep. 2025 Aug 6;15(1):28713. doi: 10.1038/s41598-025-13487-1. Sci Rep. 2025. PMID: 40770217 Free PMC article. Clinical Trial.
Eighty-eight participants (age: 63.5 [52.5, 70.3], male: 57.95%) were assigned to active PNS stimulation (n = 45) or sham procedure (n = 43). Efficacy was assessed using accelerometer-measured tremor amplitude (m/s2), clinician-rated tremor severity using the Tremor …
Eighty-eight participants (age: 63.5 [52.5, 70.3], male: 57.95%) were assigned to active PNS stimulation (n = 45) or sham procedure ( …
Global, regional, and national burden of meningitis, its risk factors, and aetiologies, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023.
GBD 2023 Meningitis & Antimicrobial Resistance Collaborators. GBD 2023 Meningitis & Antimicrobial Resistance Collaborators. Lancet Neurol. 2026 Mar 27:S1474-4422(26)00101-8. doi: 10.1016/S1474-4422(26)00101-8. Online ahead of print. Lancet Neurol. 2026. PMID: 41911930
The four WHO-defined preventable meningitis pathogens of interest (S pneumoniae, N meningitidis, Haemophilus influenzae, and Group B streptococcus) contributed to 98 700 deaths (77 000-127 000) and 594 000 cases (514 000-686 000). ...Despite marked progress in reducing bac …
The four WHO-defined preventable meningitis pathogens of interest (S pneumoniae, N meningitidis, Haemophilus influenzae, and Group B …
Unsafe nursing documentation: A qualitative content analysis.
Tajabadi A, Ahmadi F, Sadooghi Asl A, Vaismoradi M. Tajabadi A, et al. Nurs Ethics. 2020 Aug;27(5):1213-1224. doi: 10.1177/0969733019871682. Epub 2019 Sep 2. Nurs Ethics. 2020. PMID: 31476968
METHODS: This qualitative study was carried out using a qualitative content analysis of data collected from 2018 to 2019 in two urban areas of Iran. Semi-structured interviews (n = 15), observations, and reviews of patients' medical files were used for data collection. ...
METHODS: This qualitative study was carried out using a qualitative content analysis of data collected from 2018 to 2019 in two urban areas …
Examining the therapeutic potential and side effects of calcium channel blockers in mortality and morbidity of patients with stroke: A systematic review of pre-clinical and clinical studies.
Hatamian S, Abdi A, Asl FSS, Tafazolimoghadam A, Tavasol A, Nejad SAM, Madadi R, Tajabadi Z, Dehghani M, Ahmadpoor N, Fathi M, Hajiesmaeili M, Nooraei N. Hatamian S, et al. IBRO Neurosci Rep. 2025 Jan 8;18:222-243. doi: 10.1016/j.ibneur.2025.01.002. eCollection 2025 Jun. IBRO Neurosci Rep. 2025. PMID: 40584424 Free PMC article. Review.
On the other hand, the stroke recovery phase depends on activating calcium channels and N-methyl-D-aspartate (NMDA) receptors. Considering these issues, one of the interdisciplinary challenges of neurology and cardiology is the use of these drugs in hypertensive patients w …
On the other hand, the stroke recovery phase depends on activating calcium channels and N-methyl-D-aspartate (NMDA) receptors. Consid …
14 results